(Q80210230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Feller N

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

van der Pol MA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

van Stijn A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Weijers GW

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Westra AH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Evertse BW

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ossenkoppele GJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Schuurhuis GJ

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1380-1390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15201848%20AND%20SRC:MED&resulttype=core&format=json

Characterization of aberrant phenotypes in acute myeloblastic leukemia

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Detection of minimal residual disease in acute leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Minimal residual disease evaluation in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Dosing strategies for anticancer drugs: the good, the bad and body-surface area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403405

7 January 2021